Sex differences in subjective and objective responses to a stimulant medication (methylphenidate): Comparisons between overweight/obese adults with and without binge-eating disorder

International Journal of Eating Disorders

Volumn 49, Issue 5, 2016, Pages 473-481

  Davis, Caroline ^a,b   Levitan, Robert D ^b   Kaplan, Allan S ^b   Carter Major, Jacqueline C ^c   Kennedy, James L ^b  

^a YORK UNIVERSITY   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

appetite; binge eating disorder; food consumption; methylphenidate; mood; sex differences

Indexed keywords

METHYLPHENIDATE; PLACEBO; CENTRAL STIMULANT AGENT;

ADULT; APPETITE; ARTICLE; BINGE EATING DISORDER; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; FEMALE; FOOD INTAKE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD; OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SINGLE DRUG DOSE; AFFECT; BINGE-EATING DISORDER; COMPARATIVE STUDY; COMPLICATION; DRUG EFFECTS; MIDDLE AGED; OVERWEIGHT; SEXUAL DEVELOPMENT; YOUNG ADULT;

ADULT; AFFECT; APPETITE; BINGE-EATING DISORDER; CENTRAL NERVOUS SYSTEM STIMULANTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; METHYLPHENIDATE; MIDDLE AGED; OBESITY; OVERWEIGHT; SEX CHARACTERISTICS; YOUNG ADULT;

EID: 84952332994     PISSN: 02763478     EISSN: 1098108X     Source Type: Journal    
DOI: 10.1002/eat.22493     Document Type: Article

References (39)

1. Davis C, Patte K, Levitan RD, Carter J, Kaplan AS, Zai C, et al., A psycho-genetic study of the links between binge-eating disorder and attention deficit (hyperactivity) disorder. J Psychiatr Res 2009; 43: 687-696.
2. Kessler RC, Berglund PA, Chiu WT, Dietz AC, Hudson JI, Shahly V, et al., The prevalence and correlates of binge-eating disorder in the World Health Organization World Mental Health Surveys. Biol Psychiatry 2013; 73: 904-914.
3. Muller A, Claes L, Wilderjans TF, de Zwaan M., Temperament subtypes in treatment seeking obese individuals: A latent profile analysis. Eur Eating Disord Rev 2014; 22: 260-266.
4. Fernandez-Aranda F, Aguera Z, Castro R, Jimenez-Murcia s, Ramos-Quiroga JA, Bosch R, et al., ADHD symptomatology in eating disorders: A secondary psychopathological measure of severity? BMC Psychiatry 2013; 13: 166.
5. Davis C., Attention deficit/hyperactivity disorder: Associations with overeating and obesity. Curr Psychiatry Rep 2010; 12: 389-395.
6. McElroy SL, Hudson JI, Mitchell JE, Wilfley D, Ferreira-Cornwell MC, Gao J, et al., Efficacy and safety of lisdexamfetamine for treatment of adults with moderate to severe binge-eating disorder. A randomized control trial. JAMA Psychiatry 2015; 72: 235-246.
7. Agh T, Kovacs G, Pawaskar M, Supina D, Inotai A, Voko Z., Epidemiology, health-related quality of life and economic burden of binge-eating disorder: A systematic literature review. Eat Weight Disord 2015; 20: 1-12.
8. Quilty LC, Knyahnytska Y, Davis C, Kaplan AS., Psychostimulant mediation in the treatment of binge-eating disorder: A pilot investigation. Paper presented at the annual meeting of the Society for Biological Psychiatry. Toronto, May, 2015.
9. Klump KL, Racine S, Hildebrandt B, Sisk CL., Sex differences in binge eating patterns in male and female adult rats. Int J Eat Disord 2013; 46: 729-736.
10. Davis C. Fattore,. Gender differences in cannabis addiction and dependence. In:, Fattore L, Campolongo P, editors. Cannabinoids and Modulation of Emotion, Memory, and Motivation. New York: Springer, 2015, pp. 283-325.
11. Evans SM, Foltin RW., Does the response to cocaine differ as a function of sex or hormonal status in human and non-human primates? Horm Behav 2010; 58: 13-21.
12. Roeding RL, Perna MK, Cummins ED, Peterson DJ, Palmatier MI, Brown RW., Sex differences in adolescent methylphenidate sensitization: Effects on glial cell-derived neurotropic factor and brain-derived neurotropic factor. Behav Brain Res 2014; 273: 139-143.
13. Vansickel AR, Stoops WW, Rush CR., Human sex differences in d-amphetamine self-administration. Addiction 2010; 105: 727-731.
14. Schneider BN, Enenbach M., Managing the risks of ADHD treatments. Curr Psychiatry Rep 2014; 16: 479-486.
15. Thanos PK, Robinson LS, Steier J, Hwang YF, Cooper T, Swanson JM, et al., A pharmacokinetic model or oral methylphenidate in the rat and effects on behavior. Pharmacol Biochem Behav 2015; 131: 143-153.
16. Fredriksen M, Dahl AA, Martinsen EW, Klungsoyr O, Haavik J, Peleikis DE., Effectiveness of one-year pharmacological treatment of adult attention-deficit/hyperactivity disorder (ADHD): An open-label prospective study of time in treatment, dose, side-effects and comorbidity. Eur Neuropsychopharmacol 2014; 24: 1873-1884.
17. Sahin S, Yuce M, Alacam H, Karabekiroglu K, Say GN, Salis O., Effect of methylphenidate treatment on appetite and levels of leptin, ghrelin, adiponectin, and brain-derived neurotropic factor in children and adolescents with attention deficit and hyperactivity disorder. Int J Psychiatry Clin Prac 2014; 18: 280-287.
18. Davis C, Fattore L, Kaplan AS, Carter JC, Levitan RD, Kennedy JL., (2012) The suppression of appetite and food consumption by methylphenidate: The moderating effects of gender and weight in healthy adults. Int J Neuropsychopharmacol 2012; 15: 181-187.
19. Volkow ND, Wang GJ, Fowler JS, Gatley SJ, Logan J, Ding YS, et al., Dopamine transporter occupancies in the human brain induced by therapeutic doses or oral methylphenidate. Am J Psychiatry 1998; 155: 1325-1331.
20. Goldschmidt AB, Le Grange D, Powers P, Crow SJ, Hill LL, Peterson CB, et al., Eating disorder symptomatology in normal-weight vs. obese individuals with binge-eating disorder. Obesity (Silver Spring) 2011; 19: 1515-1518.
21. Dingemans AE, van Furth EF., Binge-eating disorder psychopathology in normal weight and obese individuals. Int J Eat Disord 2012; 45: 135-138.
22. Barry DT, Grilo CM, Masheb RM., Comparison of patients with bulimia nervosa, obese patients with binge-eating disorder, and non-obese patients with binge-eating disorder. J Nerv Ment Dis 2003; 191: 589-584.
23. Carrad I, Van der Linden M, Golay A., Comparison of obese and nonobese individuals with binge-eating disorder: Delicate boundry between binge-eating disorder and non-purging bulimia nervosa. Eur Eat Disorders Rev 2012; 20: 350-354.
24. American Psychiatric Association. Diagnostic and Statistical Manual-5, 5th ed. Washington: APA, 2013.
25. Cepeda-Benito A, Gleaves DH, Williams TL, Erath SA., The development and validation of the state and trait food-cravings questionnaires. Behav Ther 2000; 31: 151-173.
26. Moreno S, Rodriguez S, Fernandez MC, Tamez J, Cepeda-Benito A., Clinical validation of the trait and state versions of the Food Craving Questionnaire. Assessment 2008; 15: 375-387.
27. Nijs IM, Franken IH, Muris P., The modified Trait and State Food-Craving Questionnaire: Development and validation of a general index of food craving. Appetite 2007; 49: 38-46.
28. Volkow ND, Wang G-J, Ma Y, Fowler JS, Wong C, Jayne M, et al., Effects of expectation on the brain metabolic responses to methylphenidate and to its placebo in non-drug abusing subjects. NeuroImage 2006; 32: 1782-1792.
29. Wang G-J, Volkow ND, Hitzemann RJ, Wong C, Angrist B, Burr G, et al., Behavioral and cardiovascular effects of intravenous methylphenidate in normal subjects and cocaine abusers. Eur Addict Res 1997; 3: 49-54.
30. Anker JJ, Carroll ME., Females are more vulnerable to drug abuse than males: Evidence form preclinical studies and the role of ovarian hormones. Curr Top Behav Neurosci 2011; 8: 73-96.
31. Terner JM, de Wit H., Menstrual cycle phase and responses to drugs of abuse in humans. Drug Alcohol Depend 2006; 84: 1-13.
32. Peterson BM, Mermelstein PG, Meisel RL., Estradiol mediates dendritic spine plasticity in the nucleus accumbens core through activation of mGluR5. Brain Struct Funct 2015; 220: 2415-2422.
33. Milesi-Halle A, Hambuchen MD, McMillan DE., The pharmacokinetics of methamphetamine self-administration in male and female rats. Drug Alcohol Dep 2015; 150: 164-169.
34. Lynch WJ, Kalayasiri R, Sughondhabirom A, Pittman B, Coric V, Morgan PT, et al., Subjective responses and cardiovascular effects of self-administered cocaine in cocaine-abusing men and women. Addict Biol 2008; 13: 403-410.
35. Schauer PR, Kashyap SR, Wolski K, Breithauer SA, Kirwan JP, Pothier CE, et al., Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012; 366: 1567-1576.
36. Citrome L., Lisdexamfetamine for binge-eating disorder in adults: A systematic review of the efficacy and safety profile for this newly approved indication-What is the number needed to treat, number needed to harm and likelihood to be helped or harmed? Int J Clin Prac 2015; 69: 410-421.
37. Hilderbrand ER, Lasek AW., Sex differences in cocaine conditioned place preference in C57BL/6J mice. Neuroreport 2014; 25: 105-109.
38. Mateos-Garcia A, Manzanedo C, Rodriguez-Arias M, Aguilar MA, Reig-Sanchis E, Navarro-Frances CI, et al., Sex differences in the long-lasting consequences of adolescent ethanol exposure for the rewarding effects of cocaine in mice. Psychopharmacol 2015; 232: 2995-3007.
39. Moran-Santa Maria MM, Flanagan J, Brady K., Ovarian hormones and drug abuse. Curr Psychiatry Rep 2014; 16: Article Number 511.